Betsy Cogan, Regis C. Pearson, C. Paton, N. Jenkins, J. Cooper
{"title":"4周富含山核桃的饮食对健康老年人认知功能的影响","authors":"Betsy Cogan, Regis C. Pearson, C. Paton, N. Jenkins, J. Cooper","doi":"10.3233/nha-220181","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Pecans are rich in nutrients known to benefit cognition. OBJECTIVE: To examine the effect of daily pecan consumption on cognitive function in older adults. METHODS: In this randomized controlled trial, 42 adults (50–75y) either consumed 68 g of pecans/day for 4 weeks (pecan; n = 21) or avoided all nuts (control; n = 21). At pre- (V1) and post-intervention (V2) visits, cognitive function was assessed using a fluid composite score and four subtests from the NIH toolbox cognitive battery (NIHTB-CB) (Flanker Test, Digital Change Card Sort Test (DCCS), Picture Sequence Memory Test (PSMT), NIHTB Auditory Verbal Learning Test (RAVLT)) at fasting, 30- and 210-min after a high saturated fat meal void of pecans. RESULTS: From V1 to V2, fasting and postprandial cognitive performance did not differ between groups. There were improvements in both groups for fasting fluid composite score (p < 0.001) and performance on RAVLT, PSMT, DCCS, and Flanker tests from V1 to V2 (p < 0.001 for all), with no differences between groups. Additionally, postprandial performance on RAVLT, PSMT, and Flanker tests improved at V2 (p < 0.01 for each), with no differences between groups. CONCLUSIONS: A short-term pecan-enriched diet did not provide additional cognitive benefits in healthy older adults in the fasted or postprandial state.","PeriodicalId":37419,"journal":{"name":"Nutrition and Healthy Aging","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of a 4-week pecan-enriched diet on cognitive function in healthy older adults\",\"authors\":\"Betsy Cogan, Regis C. Pearson, C. Paton, N. Jenkins, J. Cooper\",\"doi\":\"10.3233/nha-220181\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: Pecans are rich in nutrients known to benefit cognition. OBJECTIVE: To examine the effect of daily pecan consumption on cognitive function in older adults. METHODS: In this randomized controlled trial, 42 adults (50–75y) either consumed 68 g of pecans/day for 4 weeks (pecan; n = 21) or avoided all nuts (control; n = 21). At pre- (V1) and post-intervention (V2) visits, cognitive function was assessed using a fluid composite score and four subtests from the NIH toolbox cognitive battery (NIHTB-CB) (Flanker Test, Digital Change Card Sort Test (DCCS), Picture Sequence Memory Test (PSMT), NIHTB Auditory Verbal Learning Test (RAVLT)) at fasting, 30- and 210-min after a high saturated fat meal void of pecans. RESULTS: From V1 to V2, fasting and postprandial cognitive performance did not differ between groups. There were improvements in both groups for fasting fluid composite score (p < 0.001) and performance on RAVLT, PSMT, DCCS, and Flanker tests from V1 to V2 (p < 0.001 for all), with no differences between groups. Additionally, postprandial performance on RAVLT, PSMT, and Flanker tests improved at V2 (p < 0.01 for each), with no differences between groups. CONCLUSIONS: A short-term pecan-enriched diet did not provide additional cognitive benefits in healthy older adults in the fasted or postprandial state.\",\"PeriodicalId\":37419,\"journal\":{\"name\":\"Nutrition and Healthy Aging\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nutrition and Healthy Aging\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3233/nha-220181\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition and Healthy Aging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/nha-220181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Effects of a 4-week pecan-enriched diet on cognitive function in healthy older adults
BACKGROUND: Pecans are rich in nutrients known to benefit cognition. OBJECTIVE: To examine the effect of daily pecan consumption on cognitive function in older adults. METHODS: In this randomized controlled trial, 42 adults (50–75y) either consumed 68 g of pecans/day for 4 weeks (pecan; n = 21) or avoided all nuts (control; n = 21). At pre- (V1) and post-intervention (V2) visits, cognitive function was assessed using a fluid composite score and four subtests from the NIH toolbox cognitive battery (NIHTB-CB) (Flanker Test, Digital Change Card Sort Test (DCCS), Picture Sequence Memory Test (PSMT), NIHTB Auditory Verbal Learning Test (RAVLT)) at fasting, 30- and 210-min after a high saturated fat meal void of pecans. RESULTS: From V1 to V2, fasting and postprandial cognitive performance did not differ between groups. There were improvements in both groups for fasting fluid composite score (p < 0.001) and performance on RAVLT, PSMT, DCCS, and Flanker tests from V1 to V2 (p < 0.001 for all), with no differences between groups. Additionally, postprandial performance on RAVLT, PSMT, and Flanker tests improved at V2 (p < 0.01 for each), with no differences between groups. CONCLUSIONS: A short-term pecan-enriched diet did not provide additional cognitive benefits in healthy older adults in the fasted or postprandial state.
期刊介绍:
Nutrition and Healthy Aging is an international forum for research on nutrition as a means of promoting healthy aging. It is particularly concerned with the impact of nutritional interventions on the metabolic and molecular mechanisms which modulate aging and age-associated diseases, including both biological responses on the part of the organism itself and its micro biome. Results emanating from both model organisms and clinical trials will be considered. With regards to the latter, the journal will be rigorous in only accepting for publication well controlled, randomized human intervention trials that conform broadly with the current EFSA and US FDA guidelines for nutritional clinical studies. The journal will publish research articles, short communications, critical reviews and conference summaries, whilst open peer commentaries will be welcomed.